Proton pump inhibitors, fracture risk and selection bias: three studies, same database, two answers

por de Vries, F., van Staa, T.-P., Leufkens, H. G. M.
Publicado 2010

Use of β-Blockers and the Risk of Hip/Femur Fracture in the United Kingdom and The Netherlands

por de Vries, F., Souverein, P. C., Cooper, C., Leufkens, H. G. M., van Staa, T. P.
Publicado 2007

Closed incision prophylactic negative pressure wound therapy in patients undergoing major complex abdominal wall repair

por de Vries, F. E. E., Atema, J. J., Lapid, O., Obdeijn, M. C., Boermeester, M. A.
Publicado 2017

Antipsychotic use and the risk of hip/femur fracture: a population-based case–control study

por Pouwels, S., van Staa, T. P., Egberts, A. C. G., Leufkens, H. G. M., Cooper, C., de Vries, F.
Publicado 2009

Potential Impact of Benzodiazepine Use on the Rate of Hip Fractures in Five Large European Countries and the United States

por Khong, T. P., de Vries, F., Goldenberg, J. S. B., Klungel, O. H., Robinson, N. J., Ibáñez, Luisa, Petri, H.
Publicado 2012

Impact of COVID-19 lockdown on physical activity and sedentary behaviour in Dutch cardiovascular disease patients

por van Bakel, B. M. A., Bakker, E. A., de Vries, F., Thijssen, D. H. J., Eijsvogels, T. M. H.
Publicado 2021

Association between use of antidepressants or benzodiazepines and the risk of subsequent fracture among those aged 65+ in the Netherlands

por van de Ven, L. I., Klop, C., Overbeek, J. A., de Vries, F., Burden, A. M., Janssen, P. K.
Publicado 2018

Fracture rate in patients with myasthenia gravis: the general practice research database

por Pouwels, S., de Boer, A., Javaid, M. K., Hilton-Jones, D., Verschuuren, J., Cooper, C., Leufkens, H. G., de Vries, F.
Publicado 2012

Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study

por Pouwels, S., Lalmohamed, A., Souverein, P., Cooper, C., Veldt, B. J., Leufkens, H. G., de Boer, A., van Staa, T., de Vries, F.
Publicado 2010

Dopaminergic drugs and the risk of hip or femur fracture: a population-based case–control study

por Arbouw, M. E. L., Movig, K. L. L., van Staa, T. P., Egberts, A. C. G., Souverein, P. C., de Vries, F.
Publicado 2010

Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial

por Klop, C., de Vries, F., Vinks, T., Kooij, M. J., van Staa, T. P., Bijlsma, J. W. J., Egberts, A. C. G., Bouvy, M. L.
Publicado 2013

Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures

por Lalmohamed, A., Welsing, P. M. J., Lems, W. F., Jacobs, J. W. G., Kanis, J. A., Johansson, H., De Boer, A., De Vries, F.
Publicado 2011

Heavy-Metal Concentrations in Small Mammals from a Diffusely Polluted Floodplain: Importance of Species- and Location-Specific Characteristics

por Wijnhoven, S., Leuven, R. S. E. W., van der Velde, G., Jungheim, G., Koelemij, E. I., de Vries, F. T., Eijsackers, H. J. P., Smits, A. J. M.
Publicado 2007

Risk of infections in patients with gout: a population-based cohort study

por Spaetgens, B., de Vries, F., Driessen, J. H. M., Leufkens, H. G., Souverein, P. C., Boonen, A., van der Meer, J. W. M., Joosten, L. A. B.
Publicado 2017

Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort

por Bours, S., de Vries, F., van den Bergh, J. P. W., Lalmohamed, A., van Staa, T. P., Leufkens, H. G. M., Geusens, P. P. P., Drent, M., Harvey, N. C.
Publicado 2015

The epidemiology of fractures in Denmark in 2011

por Driessen, J. H. M., Hansen, L., Eriksen, S. A., van Onzenoort, H. A. W., Henry, R. M. A., van den Bergh, J., Abrahamsen, B., Vestergaard, P., de Vries, F.
Publicado 2016

Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosis

por Oshagbemi, O. A., Driessen, J. H. M., Pieffers, A., Wouters, E. F. M., Geusens, P., Vestergaard, P., van den Bergh, J., Franssen, F. M. E., de Vries, F.
Publicado 2017

Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000–2010

por Klop, C., Gibson-Smith, D., Elders, P. J. M., Welsing, P. M. J., Leufkens, H. G. M., Harvey, N. C., Bijlsma, J. W. J., van Staa, T.-P., de Vries, F.
Publicado 2015

All-cause mortality with current and past use of antidepressants or benzodiazepines after major osteoporotic and hip fracture

por de Bruin, I. J. A., Klop, C., Wyers, C. E., Overbeek, J. A., Geusens, P. P. M. M., van den Bergh, J. P. W., Driessen, J. H. M., de Vries, F.
Publicado 2019

Use of anti-depressants and the risk of fracture of the hip or femur

por van den Brand, M. W. M., Samson, M. M., Pouwels, S., van Staa, T. P., Thio, B., Cooper, C., Leufkens, H. G. M., Egberts, A. C. G., Verhaar, H. J. J., de Vries, F.
Publicado 2009